- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | First Faculty of Medicine, Third Faculty of Medicine
- Activity of c-Src as a novel target for the inhibition of mTOR signaling in human diseasesPublication without faculty affiliation
- Different effects of the inhibition of Src activity on Akt/PKB in melanoma cells with wild BRAF and mutated BRAF V600E2013 | First Faculty of Medicine
